Health tech startup Karius raises $165 million
Fewed by - Muzammil Zafar
California startup Karius has successfully raised 165 million USD from Japanese Vision Fund investor Softbank, which also backs WeWork, for its liquid biopsy technology which is currently being utilized to investigate pathogens in immunocompromised children, finding causes of complex pneumonia, fungal infections and endocarditis. The rapidly growing company's testing technique has been published and validated in the Nature Microbiology journal.
technology
california
japan
nature
softbank
wework
united-states
microbiology
pneumonia
karius
vision-fund
invest
liquid
biopsy
pathogen
immunocompromised
fungal
endocarditis
Mon Feb 24 -
TechCrunch